{"component": "definition", "props": {"groups": [{"snippet": "means a list of additional information requirements, not included in one of the schedules, to be added to one or more schedules, as the case may be, depending on the type of instrument and/or transaction for which a prospectus or base prospectus is drawn up;", "samples": [{"hash": "708jAQLdDor", "uri": "https://www.legislation.gov.uk/eur/2004/809/2012-07-01/data.pdf?view=extent", "label": "www.legislation.gov.uk", "score": 11.1560574949, "published": false}, {"hash": "k0465EN5i3u", "uri": "https://www.cliffordchance.com/content/dam/cliffordchance/briefings/2012/06/prospectus-directive-regulation-as-amended-consolidated-version-marked-to-show-changes-made-by-the-amending-regulations.pdf", "label": "www.cliffordchance.com", "score": 6.2265571526, "published": false}, {"hash": "bOrunL8vfe3", "uri": "https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CONSLEG:2004R0809:20090101:EN:PDF", "label": "eur-lex.europa.eu", "score": 5.2368240931, "published": false}], "snippet_links": [{"key": "a-list", "type": "definition", "offset": [6, 12]}, {"key": "additional-information-requirements", "type": "clause", "offset": [16, 51]}, {"key": "not-included", "type": "clause", "offset": [53, 65]}, {"key": "the-schedules", "type": "definition", "offset": [76, 89]}, {"key": "to-be-added", "type": "clause", "offset": [91, 102]}, {"key": "the-case", "type": "definition", "offset": [132, 140]}, {"key": "depending-on-the", "type": "clause", "offset": [149, 165]}, {"key": "type-of", "type": "definition", "offset": [166, 173]}, {"key": "base-prospectus", "type": "clause", "offset": [230, 245]}], "size": 15, "hash": "3f3496ef25940eb788d3671f6dcd2dea", "id": 1}, {"snippet": "means any non-polypeptide chemical (optionally containing one or more chiral centers), having a molecular weight of more than [*] and less than [*], that (a) is not a Basic Chemical or a Functional Compound, and (b) is intended for addition to one or more Templates to make a Functional Compound.", "samples": [{"hash": "evowhaiHJCm", "uri": "/contracts/evowhaiHJCm#building-block", "label": "License Agreement (Codexis Inc)", "score": 21.257357974, "published": true}, {"hash": "i8zvo8Bfi6n", "uri": "/contracts/i8zvo8Bfi6n#building-block", "label": "License Agreement (Codexis Inc)", "score": 21.0, "published": true}, {"hash": "WcT3ofm3t7", "uri": "/contracts/WcT3ofm3t7#building-block", "label": "License Agreement (Codexis Inc)", "score": 21.0, "published": true}], "snippet_links": [{"key": "any-non", "type": "clause", "offset": [6, 13]}, {"key": "having-a", "type": "definition", "offset": [87, 95]}, {"key": "basic-chemical", "type": "definition", "offset": [167, 181]}, {"key": "functional-compound", "type": "definition", "offset": [187, 206]}], "size": 6, "hash": "d835235aa31f5bfbb14438c6b1b2ce4a", "id": 2}, {"snippet": "means, individually, each of the Antibodies and each of the Anticalin proteins used in a Product. A Building Block can be either an Antibody Building Block or an Anticalin Building Block.", "samples": [{"hash": "5Y3X6znvggn", "uri": "/contracts/5Y3X6znvggn#building-block", "label": "License and Collaboration Agreement (Pieris Pharmaceuticals, Inc.)", "score": 29.3148528405, "published": true}, {"hash": "eq5ER0Oz68j", "uri": "/contracts/eq5ER0Oz68j#building-block", "label": "License and Collaboration Agreement (Pieris Pharmaceuticals, Inc.)", "score": 28.241615332, "published": true}, {"hash": "ioG1AthlsAy", "uri": "https://www.pieris.com/investors/sec-filings/annual-reports/content/0001583648-18-000022/0001583648-18-000022.pdf", "label": "Amendment", "score": 13.1574264203, "published": false}], "snippet_links": [{"key": "antibody-building-block", "type": "definition", "offset": [132, 155]}], "size": 6, "hash": "e47ae5ce3a160fa01ac1c8a1a679cb80", "id": 3}, {"snippet": "means Block No. 1 also named as Block \u201cQUEEN\u201d and Block 2 also named as Block \u201cKING\u201d and collectively called as Buildings / Blocks.", "samples": [{"hash": "aoaPFOK9PXl", "uri": "/contracts/aoaPFOK9PXl#building-block", "label": "Sale Agreement", "score": 34.2057117899, "published": true}, {"hash": "8nXxNhlmeSm", "uri": "/contracts/8nXxNhlmeSm#building-block", "label": "Residential Sale Agreement", "score": 34.2057117899, "published": true}], "snippet_links": [{"key": "block-no", "type": "clause", "offset": [6, 14]}, {"key": "block-2", "type": "definition", "offset": [50, 57]}], "size": 2, "hash": "1448e45fde403d47b905fc868391326a", "id": 4}, {"snippet": "means any [****], that (a) is not a [****] or a [****], and (b) is intended for addition to one or more [****] to make a [****].", "samples": [{"hash": "8dq6POGfpXw", "uri": "/contracts/8dq6POGfpXw#building-block", "label": "Cross License Agreement (Maxygen Inc)", "score": 21.0, "published": true}], "snippet_links": [], "size": 1, "hash": "ce4913df4ffec40fca60a8e466e4391c", "id": 5}, {"snippet": "shall have the meaning attributed to the term in recital F of this Agreement. 10", "samples": [{"hash": "ea8gwYmSNT9", "uri": "/contracts/ea8gwYmSNT9#building-block", "label": "Lease Agreement", "score": 24.6328073301, "published": true}], "snippet_links": [{"key": "the-term", "type": "definition", "offset": [37, 45]}, {"key": "f-of-this-agreement", "type": "clause", "offset": [57, 76]}], "size": 1, "hash": "58325f967334fb887869c40024c49021", "id": 6}, {"snippet": "means an element or group of elements representing the smallest feasible level of unbundling capable of being tariffed and offered as a service.", "samples": [{"hash": "aEMcrele3gH", "uri": "https://apps.puc.state.or.us/orders/2004ords/04-012.pdf", "label": "apps.puc.state.or.us", "score": 10.8165639973, "published": false}], "snippet_links": [{"key": "capable-of", "type": "definition", "offset": [93, 103]}, {"key": "as-a-service", "type": "definition", "offset": [131, 143]}], "size": 1, "hash": "391cd219319acd8d98afa82bc340369e", "id": 7}, {"snippet": "2: Byzantine Agreement", "samples": [{"hash": "gCo0NnPXqmc", "uri": "/contracts/gCo0NnPXqmc#building-block", "label": "Byzantine Agreement", "score": 28.7190917971, "published": true}], "snippet_links": [{"key": "byzantine-agreement", "type": "clause", "offset": [3, 22]}], "size": 1, "hash": "fc199edf048e20b15e91e18a933be887", "id": 8}, {"snippet": "means any of \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 \u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 \u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 C Building Block D1 Building \u2587\u2587\u2587\u2587\u2587 \u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 \u2587 \u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 \u2587;", "samples": [{"hash": "69o99jwO0TI", "uri": "/contracts/69o99jwO0TI#building-block", "label": "Section 106 Agreement", "score": 21.0, "published": true}], "snippet_links": [], "size": 1, "hash": "64e269b5277f527d3fabb8442619591a", "id": 9}, {"snippet": "means, individually, the Antibody and the Anticalin proteins used in the Product. A Building Block can be either an Antibody Building Block or an Anticalin Building Block. \u201cBusiness Day\u201d means a day other than a Saturday, Sunday, or a bank or other public holiday in Munich, Germany or Boston, Massachusetts. \u201cCalendar Quarter\u201d means the respective periods of three (3) consecutive calendar months ending on March 31, June 30, September 30 and December 31 of each Calendar Year. \u201cCalendar Year\u201d means each successive period of twelve (12) months commencing on January 1 and ending on December 31. \u201cChina\u201d means the PRC, Hong Kong, Macau, and Taiwan. \u201cChange of Control\u201d means with respect to a Party, (a) completion of a merger,", "samples": [{"hash": "6jFiuwHx4Pc", "uri": "/contracts/6jFiuwHx4Pc#building-block", "label": "Exclusive Product License Agreement (Pieris Pharmaceuticals, Inc.)", "score": 30.5920602327, "published": true}], "snippet_links": [{"key": "the-product", "type": "clause", "offset": [69, 80]}, {"key": "antibody-building-block", "type": "definition", "offset": [116, 139]}, {"key": "business-day", "type": "definition", "offset": [173, 185]}, {"key": "a-day", "type": "definition", "offset": [193, 198]}, {"key": "a-bank", "type": "clause", "offset": [233, 239]}, {"key": "public-holiday", "type": "clause", "offset": [249, 263]}, {"key": "calendar-quarter", "type": "definition", "offset": [310, 326]}, {"key": "periods-of", "type": "clause", "offset": [349, 359]}, {"key": "calendar-months", "type": "clause", "offset": [382, 397]}, {"key": "on-march", "type": "clause", "offset": [405, 413]}, {"key": "each-calendar-year", "type": "definition", "offset": [459, 477]}, {"key": "period-of", "type": "clause", "offset": [517, 526]}, {"key": "commencing-on", "type": "clause", "offset": [546, 559]}, {"key": "on-december", "type": "clause", "offset": [581, 592]}, {"key": "the-prc", "type": "definition", "offset": [611, 618]}, {"key": "hong-kong", "type": "definition", "offset": [620, 629]}, {"key": "change-of-control", "type": "clause", "offset": [651, 668]}, {"key": "with-respect-to", "type": "clause", "offset": [676, 691]}, {"key": "a-party", "type": "clause", "offset": [692, 699]}, {"key": "completion-of-a", "type": "clause", "offset": [705, 720]}], "size": 1, "hash": "220626c0f5933e4e3b75ed70df98ace0", "id": 10}], "next_curs": "ClsSVWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjcLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIXYnVpbGRpbmctYmxvY2sjMDAwMDAwMGEMogECZW4YACAA", "definition": {"snippet": "means a list of additional information requirements, not included in one of the schedules, to be added to one or more schedules, as the case may be, depending on the type of instrument and/or transaction for which a prospectus or base prospectus is drawn up;", "title": "Building Block", "size": 37, "id": "building-block", "examples": ["The Learn API(s) are provided in the form of one of the following: a <strong>Building Block</strong> API, a REST API or a web service, that enables a &quot;connection&quot; into our servers.", "To make a claim under the limited warranty, you must contact either Microsoft Ireland Operations Limited, Customer Care Centre, Atrium <strong>Building Block</strong> B, Carmanhall Road, Sandyford Industrial Estate, Dublin 18, Ireland, or the Microsoft affiliate serving your country (see \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587/\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587).", "To make a claim under the limited warranty, you must contact either Microsoft Ireland Operations Limited, Customer Care Centre, Atrium <strong>Building Block</strong> B, Carmanhall Road, Sandyford Industrial Estate, Dublin 18, Ireland, or the Microsoft affiliate serving your country (\u2587\u2587\u2587.\u2587\u2587/\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587).", "All costs and expenses of maintaining repairing redecorating and renewing etc., of the main structure, gutters and water pipes for all purposes, drains and electric cables and wires in under or upon the Complex and enjoyed or used by the Purchasers in common with other occupiers or serving more than one Unit and main entrance and exit gates, landings and staircases of the Complex/ <strong>Building Block</strong> and enjoyed by the Purchasers or used by their in common as aforesaid and the boundary walls, compounds etc.", "Buyer retains all rights it has to the technology contained in the Buyer Software packaging and testing for Update Express Support Packages (USXP) as specified in Modular and Blade Systems <strong>Building Block</strong> Software Integration Guide under Buyer Proprietary ownership.", "The Allottee shall commence payment of Maintenance Charges to the Promoter after lapse of first three months from the date of Partial Completion Certificate of the respective <strong>Building Block</strong> and shall continue to pay till handover of maintenance of the project to the association of allottees and thereafter to the association of allottees.", "Notwithstanding the foregoing, for so long as SGEN is Researching, Developing, Manufacturing or Commercializing a Collaboration Product with the same SGEN <strong>Building Block</strong>, then it shall be permitted to use Dormant Candidates comprising that SGEN <strong>Building Block</strong>, but only as an experimental control in in vitro or in vivo assays directed to the Development of a Collaboration Product including the same SGEN <strong>Building Block</strong>.", "There will be up to [***] Research Candidates under this Agreement, [***] for each SGEN <strong>Building Block</strong>.", "For clarity, the license grant to SGEN under this Section 2.1 with respect to any PIRS <strong>Building Block</strong> IP within the PIRS IP is exclusive solely with respect to the applicable Collaboration Product, and no other right or license is granted to SGEN under such PIRS <strong>Building Block</strong> IP (e.g., to develop and commercialize the applicable PIRS <strong>Building Block</strong> as a standalone product or as a component of an unrelated product).", "Address: Tianxiang <strong>Building Block</strong> A 13th, Tian An Cyber Park, Futian District, Shenzhen."], "related": [["building-drain", "Building drain", "Building drain"], ["building", "Building", "Building"], ["building-square-footage", "Building Square Footage", "Building Square Footage"], ["building-common-areas", "Building Common Areas", "Building Common Areas"], ["building-area", "Building Area", "Building Area"]], "related_snippets": [], "updated": "2025-07-06T21:58:41+00:00"}, "json": true, "cursor": ""}}